ECONOMIC-EVALUATION OF CHEMOTHERAPY WITH MITOXANTRONE PLUS PREDNISONEFOR SYMPTOMATIC HORMONE-RESISTANT PROSTATE-CANCER BASED ON A CANADIANRANDOMIZED TRIAL WITH PALLIATIVE END-POINTS
Dj. Bloomfield et al., ECONOMIC-EVALUATION OF CHEMOTHERAPY WITH MITOXANTRONE PLUS PREDNISONEFOR SYMPTOMATIC HORMONE-RESISTANT PROSTATE-CANCER BASED ON A CANADIANRANDOMIZED TRIAL WITH PALLIATIVE END-POINTS, European journal of cancer, 33, 1997, pp. 5-5